Cetero Research

 

Today's Research for Tomorrow's Healthcare
 
 
+
+
+
 +
+
 
   
     
 
Complete Validated Assays
Available assay list  
Method development and validation  
LC/MS/MS  
Immunochemistry  




  Compound Matrix Sensitivity Methodology
Baclofen Urine 10.0 ng/mL LC/MS/MS
Baclofen Plasma 5.00 ng/mL LC/MS/MS
Baclofen (R & S) Rat Plasma 0.01/0.01 ng/mL – 10.0/10.0 µg/mL LC/MS/MS
Baclofen (R & S) Plasma 1.00/1.00 to 700/700 ng/mL LC/MS/MS
Balsalazide Plasma 1.00 ng/mL LC/MS/MS
Benazepril / Benazeprilat Plasma 0.5 ng/mL LC/MS/MS
Bendroflumethiazide Plasma 0.100 ng/mL LC/MS/MS
Bicalutamide Plasma 10.0 ng/mL LC/MS/MS
Bicalutamide (R) & (S) Plasma 10.0 / 1.00 ng/mL LC/MS/MS
Bisoprolol Plasma 0.200 – 150 ng/mL LC/MS/MS
Bromocriptine Plasma 4.0 – 800 pg/mL LC/MS/MS
Brompheniramine Plasma 250 pg/mL LC/MS/MS
Bumetanide Plasma 0.500 ng/mL HPLC
Buprenorphine / Norbuprenorphine (Low Range) Plasma 25.0/20.0 pg/mL LC/MS/MS
Bupropion / Hydroxybupropion / Threo / Erythroamino-Alcohol Bupropion Plasma 1.00 / 2.00 / 1.00 ng/mL LC/MS/MS
Bupropion / Hydroxybuproprion Plasma 0.980 / 1.80 ng/mL LC/MS/MS


 
 
 
|
|
|
|
|
|
 
Copyright © 2009 CRS Management. All rights reserved.
 
Developed by Web Interactive Technologies Baltimore Web Design